Literature DB >> 16275614

The immunopharmacological properties of transforming growth factor beta.

Yingying Le1, Xiaojing Yu, Lingfei Ruan, Oumei Wang, Dongfei Qi, Jingjing Zhu, Xiaofeng Lu, Yan Kong, Kun Cai, Shanshan Pang, Xianglin Shi, Ji Ming Wang.   

Abstract

Transforming growth factor-beta (TGF-beta) family members are multifunctional molecules, which play pivotal roles in regulating cell proliferation, differentiation, migration, development, tissue remodeling and repair. These events are closely associated with host immune responses and inflammation. Despite some controversies on their function in controlling dendritic and T regulatory cell development and activity, the importance of TGF-betas in the progress of autoimmunity and inflammatory diseases has been well appreciated and new aspects of their contribution continue to be recognized. Since one of the major biological properties of TGF-betas is its capacity to potently suppress immune responses, they are considered as candidates for the development of therapeutic agents to fend off undesirable damage associated with immune and inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275614     DOI: 10.1016/j.intimp.2005.07.006

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

1.  Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer's disease patients.

Authors:  B Juraskova; C Andrys; I Holmerova; D Solichova; D Hrnciarikova; H Vankova; T Vasatko; J Krejsek
Journal:  J Nutr Health Aging       Date:  2010-11       Impact factor: 4.075

2.  Protection of TGF-β1 against neuroinflammation and neurodegeneration in Aβ1-42-induced Alzheimer's disease model rats.

Authors:  Jia-Hui Chen; Kai-Fu Ke; Jian-Hua Lu; Yi-Hua Qiu; Yu-Ping Peng
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

3.  A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases.

Authors:  Ricardo Palacios; Joaquin Goni; Ivan Martinez-Forero; Jaime Iranzo; Jorge Sepulcre; Ignacio Melero; Pablo Villoslada
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

4.  Dissecting the role of transforming growth factor-β1 in topmouth culter immunobiological activity: a fundamental functional analysis.

Authors:  Pengzhi Qi; Congxin Xie; Baoying Guo; Changwen Wu
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

5.  TGF-β1 Provides Neuroprotection via Inhibition of Microglial Activation in 3-Acetylpyridine-Induced Cerebellar Ataxia Model Rats.

Authors:  Bei-Bei Cao; Xiao-Xian Zhang; Chen-Yu Du; Zhan Liu; Yi-Hua Qiu; Yu-Ping Peng
Journal:  Front Neurosci       Date:  2020-03-20       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.